| Literature DB >> 22890174 |
Patricia Georges1, Jean Legault, Serge Lavoie, Carole Grenon, André Pichette.
Abstract
Three new diterpenoids, namely 7α-hydroxyabieta-8,11,13,15-tetraen-18-oic acid, 7β,15,18-trihydroxyabieta-8,11,13-triene, 13,15-dihydroxypodocarpa-8,11,13-triene, and 12 other known compounds were isolated from buds of Pinus banksiana Lamb. All these compounds, except for 7-oxodehydroabietinol, were isolated for the first time from this plant. Their structures were elucidated by detailed spectroscopic studies and comparison with published data. All isolated compounds were tested for cytotoxic and antibacterial activities. Overall, two compounds, 7-oxodehydroabietinol and 18-nor-4,15-dihydroxyabieta-8,11,13-trien-7-one, showed moderate cytotoxicity against a human lung carcinoma cell line.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22890174 PMCID: PMC6268314 DOI: 10.3390/molecules17089716
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Diterpenes from buds of Pinus banksiana.
Cytotoxic and antibacterial activities of extracts and fractions.
| Compounds | IC50 (µg/mL) a,b | ||||
|---|---|---|---|---|---|
| A549 c | DLD-1 d | WS1 e |
|
| |
| Hexanes extract | 45 ± 4 | 44 ± 3 | 59 ± 6 | 29 ± 3 | >100 |
| CH2Cl2 extract | 26 ± 3 | 32 ± 3 | 42 ± 4 | 64 ± 5 | >100 |
| MeOH extract | >100 | >100 | >100 | >100 | >100 |
| Fraction F | 7 ± 2 | 12 ± 2 | 79 ± 3 | 51 ± 2 | >100 |
| Fraction G | 5 ± 1 | 14 ± 1 | 42 ± 3 | >100 | >100 |
| Fraction H | 6 ± 1 | 13 ± 1 | 39 ± 3 | >100 | >100 |
| Fraction K | 84 ± 1 | >100 | >100 | >100 | >100 |
| Etoposide h | 0.4 ± 0.2 | 1.7 ± 0.3 | 5.9 ± 0.6 | ||
| Chloramphenicol i | >1.6 | 0.12 ± 0.02 | |||
a Mean values for three independent assays; b Concentration inhibiting 50% cell growth; c A549, human lung carcinoma cell line; d DLD-1, human colorectal adenocarcinoma cell line; e WS1, human normal skin fibroblasts; f Staphylococcus aureus ATCC 25923; g Escherichia coli ATCC 25922; h Positive control for cytotoxicity assay; i Positive control for antibacterial assay.
1H-NMR data for compounds 1, 2 and 3 (400 MHz, a in CDCl3, b in CD3OD, J in Hz).
| Position | 1 a | 2 b | 3 a |
|---|---|---|---|
| 1 | 2.33 ( | 2.27 ( | 2.26 ( |
| 1.51 ( | 1.35 | 1.30 ( | |
| 2 | 1.79 ( | 1.81 | 1.79 ( |
| 1.69 | 1.64 ( | ||
| 3 | 1.80 ( | 1.48 | 1.51 ( |
| 1.36 | 1.31 ( | ||
| 5 | 2.51 ( | 1.76 | 1.64 ( |
| 6 | 2.14 ( | 2.20 ( | 1.80 ( |
| 1.72 ( | 1.65 | ||
| 7 | 4.81 ( | 4.86 ( | 2.79 |
| 11 | 7.23 ( | 7.21 ( | 7.04 ( |
| 12 | 7.39 ( | 7.31 ( | 6.51 ( |
| 14 | 7.46 ( | 7.64 ( | 6.42 ( |
| 15 | 3.43 ( | ||
| 3.09 ( | |||
| 16 | 5.36 ( | 1.57 ( | 0.84 ( |
| 5.06 ( | |||
| 17 | 2.14 ( | 1.57 ( | 1.17 ( |
| 18 | 3.50 ( | ||
| 3.20 ( | |||
| 19 | 1.30 ( | 0.89 ( | |
| 20 | 1.18 ( | 1.29 ( |
13C-NMR data for compounds 1, 2 and 3 (100 MHz, a in CDCl3, b in CD3OD).
| Position | 1 a | 2 b | 3 a |
|---|---|---|---|
| 1 | 37.6 ( | 38.3 ( | 40.0 ( |
| 2 | 18.5 ( | 18.5 ( | 19.9 ( |
| 3 | 36.3 ( | 34.7 ( | 36.3 ( |
| 4 | 46.9 ( | 37.5 ( | 38.9 ( |
| 5 | 39.6 ( | 42.3 ( | 45.1 ( |
| 6 | 31.4 ( | 29.8 ( | 19.9 ( |
| 7 | 68.2 ( | 70.9 ( | 31.2 ( |
| 8 | 135.8 ( | 137.6 ( | 137.5 ( |
| 9 | 148.3( | 148.1 ( | 142.7 ( |
| 10 | 37.6 (s) | 38.1 ( | 38.2 ( |
| 11 | 124.2 ( | 124.4 ( | 126.4 ( |
| 12 | 125.6 ( | 123.9 ( | 113.9 ( |
| 13 | 139.1 ( | 146.5 ( | 155.5 ( |
| 14 | 127.5 ( | 123.1 ( | 115.7 ( |
| 15 | 142.6 ( | 72.5 ( | 72.0 ( |
| 16 | 112.1 ( | 31.7 ( | 18.0 ( |
| 17 | 21.8 ( | 31.6 ( | 26.0 ( |
| 18 | 182.3 ( | 71.6 ( | |
| 19 | 16.3 ( | 17.5 ( | |
| 20 | 24.1 ( | 25.7 ( |
Figure 2Key 1H–1H COSY (▬) and HMBC (HC) correlations of compounds 1–3.
Figure 3Key NOESY () correlations of compound 2.
In vitro cytotoxicity and antibacterial activities from isolated compounds isolated from fractions F, G and H.
| Compounds | IC50 (µM) a,b | ||||
|---|---|---|---|---|---|
| A549 c | DLD-1 d | WS1 e |
|
| |
|
| >100 | >100 | >100 | >100 | >100 |
|
| >100 | >100 | >100 | >100 | >100 |
|
| >100 | >100 | >100 | >100 | >100 |
|
| >100 | >100 | >100 | >100 | >100 |
|
| >100 | >100 | >100 | >100 | >100 |
|
| >100 | >100 | >100 | >100 | >100 |
|
| 98 ± 2 | >100 | >100 | >100 | >100 |
|
| 63 ± 7 | 91 ± 9 | >100 | >100 | >100 |
|
| >100 | >100 | >100 | >100 | >100 |
|
| >100 | >100 | >100 | >100 | >100 |
|
| >100 | >100 | >100 | >100 | >100 |
|
| 34 ± 4 | 47 ± 9 | >100 | >100 | >100 |
|
| 46 ± 3 | >100 | >100 | >100 | >100 |
|
| >100 | >100 | >100 | >100 | >100 |
|
| >100 | >100 | >100 | >100 | >100 |
| Etoposide h | 0.7 ± 0.3 | 2.9 ± 0.5 | 10 ±2 | ||
| Chloramphenicoli | >5 | 0.37 ± 0.06 | |||
a Mean values for three independent assays; b Concentration inhibiting 50% cell growth; c A549, human lung carcinoma cell line; d DLD-1, human colorectal adenocarcinoma cell line; e WS1, human normal skin fibroblasts; f Staphylococcus aureus ATCC 25923; g Escherichia coli ATCC 25922; h Positive control for cytotoxicity assay; i Positive control for antibacterial assay.